Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ejendomsselskabet Symbiosen 7 ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3%   Bankruptcy risk   3.1% 3.6% 2.6% 2.6% 4.0% 2.3% 18.5% 18.5%   Credit score (0-100)   58 52 60 61 49 65 8 8   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 -0.0 -0.0 -0.0 -0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   261 154 348 432 626 1,055 0.0 0.0   EBITDA   261 154 348 432 626 1,055 0.0 0.0   EBIT   161 1.2 190 270 462 891 0.0 0.0   Pre-tax profit (PTP)   -77.8 -356.8 -25.8 -55.9 53.4 548.9 0.0 0.0   Net earnings   -60.7 -388.1 -25.8 -55.9 53.4 608.3 0.0 0.0   Pre-tax profit without non-rec. items   -77.8 -357 -25.8 -55.9 53.4 549 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   9,659 9,584 11,081 11,180 11,016 10,154 0.0 0.0   Shareholders equity total   -61.6 -450 -475 -531 -478 130 80.4 80.4   Interest-bearing liabilities   9,500 10,374 12,044 12,505 11,352 9,968 0.0 0.0   Balance sheet total (assets)   9,694 9,985 11,683 12,016 11,018 10,215 80.4 80.4   Net Debt   9,496 10,372 12,041 12,504 11,350 9,966 -80.4 -80.4     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   261 154 348 432 626 1,055 0.0 0.0   Gross profit growth   0.0% -40.9% 125.8% 24.2% 45.0% 68.5% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   9,694 9,985 11,683 12,016 11,018 10,215 80 80   Balance sheet change%   57.6% 3.0% 17.0% 2.8% -8.3% -7.3% -99.2% 0.0%   Added value   260.8 154.0 347.8 432.1 624.8 1,055.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   4,375 -227 1,339 -63 -328 -1,026 -10,154 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   61.7% 0.8% 54.7% 62.4% 73.8% 84.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.0% 0.0% 1.7% 2.2% 3.8% 8.2% 0.0% 0.0%   ROI %   2.3% 0.0% 1.7% 2.2% 3.9% 8.3% 0.0% 0.0%   ROE %   -0.8% -3.9% -0.2% -0.5% 0.5% 10.9% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   50.9% 95.5% 70.0% 69.8% 79.0% 93.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   3,641.2% 6,733.7% 3,462.2% 2,893.6% 1,812.0% 944.5% 0.0% 0.0%   Gearing %   -15,419.3% -2,307.1% -2,533.1% -2,353.6% -2,375.4% 7,643.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.0% 3.6% 1.9% 2.7% 3.4% 3.2% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.9 0.2 0.2 0.0 0.1 0.0 0.0   Current Ratio   0.0 0.9 0.2 0.2 0.0 0.1 0.0 0.0   Cash and cash equivalent   3.7 2.7 2.7 1.7 1.7 1.7 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -4,720.7 -43.9 -2,897.1 -2,793.4 -2,309.2 -562.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0